BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33102223)

  • 21. Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis.
    Ehret F; Rueß D; Blanck O; Fichte S; Chatzikonstantinou G; Wolff R; Mose L; Mose S; Fortmann T; Lehrke R; Turna M; Caglar HB; Mortasawi F; Bleif M; Krug D; Ruge MI; Fürweger C; Muacevic A
    Int J Cancer; 2024 May; ():. PubMed ID: 38720427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease.
    Marcrom SR; Foreman PM; Colvin TB; McDonald AM; Kirkland RS; Popple RA; Riley KO; Markert JM; Willey CD; Bredel M; Fiveash JB
    Adv Radiat Oncol; 2020; 5(1):34-42. PubMed ID: 32051888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis.
    Minniti G; Scaringi C; Paolini S; Lanzetta G; Romano A; Cicone F; Osti M; Enrici RM; Esposito V
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1142-8. PubMed ID: 27209508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
    Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
    Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single dose versus fractionated stereotactic radiotherapy for meningiomas.
    Lo SS; Cho KH; Hall WA; Kossow RJ; Hernandez WL; McCollow KK; Gerbi BJ; Higgins PD; Lee CK; Dusenbery KE
    Can J Neurol Sci; 2002 Aug; 29(3):240-8. PubMed ID: 12195613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy with a micro-multileaf collimator for brain metastasis in the primary motor cortex.
    Matsuda R; Hasegawa M; Tamamoto T; Ochi T; Miyasaka T; Inooka N; Hontsu S; Miura S; Takeshima Y; Tamura K; Yamada S; Nishimura F; Nakagawa I; Motoyama Y; Park YS; Nakase H
    J Radiat Res; 2022 Jan; 63(1):63-70. PubMed ID: 34927204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractionated stereotactic radiotherapy for local control of resected brain metastases.
    Traylor JI; Habib A; Patel R; Muir M; Gadot R; Briere T; Yeboa DN; Li J; Rao G
    J Neurooncol; 2019 Sep; 144(2):343-350. PubMed ID: 31313060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial.
    Churilla TM; Chowdhury IH; Handorf E; Collette L; Collette S; Dong Y; Alexander BM; Kocher M; Soffietti R; Claus EB; Weiss SE
    JAMA Oncol; 2019 Feb; 5(2):243-247. PubMed ID: 30419088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.
    Kohutek ZA; Yamada Y; Chan TA; Brennan CW; Tabar V; Gutin PH; Yang TJ; Rosenblum MK; Ballangrud Å; Young RJ; Zhang Z; Beal K
    J Neurooncol; 2015 Oct; 125(1):149-56. PubMed ID: 26307446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis.
    Palmer JD; Perlow HK; Matsui JK; Ho C; Prasad RN; Liu K; Upadhyay R; Klamer B; Wang J; Damante M; Ghose J; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Lonser R; Hardesty D; Prevedello D; Prabhu R; Elder JB; Raval RR
    J Neurooncol; 2022 Sep; 159(2):389-395. PubMed ID: 35751740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival After Stereotactic Radiosurgery (SRS) or Fractionated Stereotactic Radiotherapy (FSRT) for Cerebral Metastases in the Elderly.
    Rades D; Nguyen T; Blanck O; Schild SE
    In Vivo; 2020; 34(4):1909-1913. PubMed ID: 32606162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial.
    Lesueur P; Kao W; Leconte A; Geffrelot J; Lequesne J; Lacroix J; Brachet PE; Hrab I; Royer P; Clarisse B; Stefan D
    BMC Cancer; 2020 Feb; 20(1):147. PubMed ID: 32087691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of Seizures Prior to Single-fraction Radiosurgery or Multi-fraction Stereotactic Radiotherapy in Patients With Very Few Brain Metastases.
    Rades D; Witteler J; Kjaer TW; Tvilsted S; Schild SE
    Anticancer Res; 2020 Jun; 40(6):3499-3504. PubMed ID: 32487650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CyberKnife-based stereotactic radiosurgery or fractionated stereotactic radiotherapy in older patients with brain metastases from non-small cell lung cancer.
    Lee J; Kim HJ; Kim WC
    Radiat Oncol J; 2023 Dec; 41(4):258-266. PubMed ID: 38185930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuro-Oncology Practice Clinical Debate: stereotactic radiosurgery or fractionated stereotactic radiotherapy following surgical resection for brain metastasis.
    Palmer JD; Greenspoon J; Brown PD; Johnson DR; Roberge D
    Neurooncol Pract; 2020 Jun; 7(3):263-267. PubMed ID: 32537175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hippocampal dose during Linac-based stereotactic radiotherapy for brain metastases: An observational study.
    Fiorentino A; Tebano U; Sicignano G; Ricchetti F; Di Paola G; Aiello D; Giaj-Levra N; Mazzola R; Fersino S; Ruggieri R; Alongi F
    Phys Med; 2018 May; 49():135-138. PubMed ID: 28951047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractionated stereotactic radiosurgery for locally recurrent brain metastases after failed stereotactic radiosurgery.
    Dincoglan F; Sager O; Demiral S; Gamsiz H; Uysal B; Onal E; Ekmen A; Dirican B; Beyzadeoglu M
    Indian J Cancer; 2019; 56(2):151-156. PubMed ID: 31062735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.